One of these, peptidyl arginine deiminase type 4 (PADI4) was first reported in Japanese RA patients [12,13], and subsequently confirmed in several Asian groups and subgroups of Europeans [14–17]. Here, PADI4 is linked to rheumatoid arthritis.